Therefore, we evaluated whether AAV-based gene transfer of the mouse NAGS (mNAGS) can rescue Nags−/− mice from hyperammonemia after withdrawal of the NCG treatment, and whether the Nags gene promoter can be used to control expression of the delivered Nags gene. This evidence concerns the gene NAGS and Hyperammonemia.